Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Brief ReportBrief Report

Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments

Sebastian T. Tong, Kathryn M. Polak, Michael F. Weaver, Gabriela C. Villalobos, Wally R. Smith and Dace S. Svikis
The Journal of the American Board of Family Medicine March 2019, 32 (2) 272-278; DOI: https://doi.org/10.3122/jabfm.2019.02.180172
Sebastian T. Tong
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn M. Polak
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. Weaver
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela C. Villalobos
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wally R. Smith
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dace S. Svikis
From Virginia Commonwealth University, Richmond, VA (STT, KMP, GCV, WRS, DSS); University of Texas Health Science Center at Houston, TX (MFW)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    Substance Abuse and Mental Health Services Administration. Results from the 2016 National Survey on Drug Use and Health: detailed tables. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf. Published 2017. Accessed May 29, 2018.
  2. 2.↵
    1. Han B,
    2. Compton WM,
    3. Blanco C,
    4. Crane E,
    5. Lee J,
    6. Jones CM
    . Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 2017;167:293–301.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Han B,
    2. Compton WM,
    3. Jones CM,
    4. Cai R
    . Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the united states, 2003–2013. JAMA 2015;314:1468–78.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Jordan BK,
    2. Karg RS,
    3. Batts KR,
    4. Epstein JF,
    5. Wiesen C
    . A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders. Addict Behav 2008;33:782–98.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Office of the Surgeon General. Facing addiction in america: the surgeon general's report on alcohol, drugs, and health. Washington, D.C.: U.S. Department of Health and Human Services; 2016.
  6. 6.↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R
    . CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016;315:1624–45.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Quinones S
    . Dreamland: the true tale of America's opiate epidemic. New York, NY: Bloomsbury Press; 2016.
  8. 8.↵
    Substance Abuse and Mental Health Services Administration. Prescription drug misuse and abuse. http://www.samhsa.gov/prescription-drug-misuse-abuse. Published 2017. Accessed June 4, 2018.
  9. 9.↵
    1. Jones CM
    . Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002–2004 and 2008–2010. Drug Alcohol Depend 2013;132:95–100.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Cicero TJ,
    2. Ellis MS,
    3. Surratt HL,
    4. Kurtz SP
    . The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014;71:821–6.
    OpenUrl
  11. 11.↵
    1. Hughes A,
    2. Williams M,
    3. Lipari R,
    4. Bose J,
    5. Copello E,
    6. Kroutil L
    . Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration; 2016.
  12. 12.↵
    1. Mack KA,
    2. Zhang K,
    3. Paulozzi L,
    4. Jones C
    . Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved 2015;26:182–98.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Maree RD,
    2. Marcum ZA,
    3. Saghafi E,
    4. Weiner DK,
    5. Karp JF
    . A systematic review of opioid and benzodiazepine misuse in older adults. Am J Geriatr Psychiatry 2016;24:949–63.
    OpenUrl
  14. 14.↵
    1. Murphy Y,
    2. Wilson E,
    3. Goldner EM,
    4. Fischer B
    . Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995. Clin Drug Investig 2016;36:519–30.
    OpenUrl
  15. 15.↵
    1. Panes A,
    2. Lassalle R,
    3. Bernard M-A,
    4. Dureaud-Pournin C,
    5. Pariente A,
    6. Fourrier-Reglat A
    . Misuse of benzodiazepines in the French population: A cohort study in the Échantillon Genéraliste de Bénéficiaires between 2007 and 2012. Revue Épidémiol Santé Publique 64:S132–S133, 2016.
    OpenUrl
  16. 16.↵
    1. Bachhuber MA,
    2. Hennessy S,
    3. Cunningham CO,
    4. Starrels JL
    . Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. Am J Public Health 2016;106:686–8.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Khanra S
    . Benzodiazepine misuse: when shall we wake up? Asian J Psychiatr 2017;29:134–5.
    OpenUrl
  18. 18.↵
    1. Hwang CS,
    2. Turner LW,
    3. Kruszewski SP,
    4. Kolodny A,
    5. Alexander GC
    . Primary care physicians' knowledge and attitudes regarding prescription opioid abuse and diversion. Clin J Pain 2016;32:279–84.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Levy B,
    2. Paulozzi L,
    3. Mack KA,
    4. Jones CM
    . Trends in opioid analgesic–prescribing rates by specialty, U.S., 2007–2012. Am J Prev Med 2015;49:409–13.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kroll DS,
    2. Nieva HR,
    3. Barsky AJ,
    4. Linder JA
    . Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. J Gen Intern Med 2016;31:1027–34.
    OpenUrl
  21. 21.↵
    1. Park TW,
    2. Saitz R,
    3. Nelson KP,
    4. Xuan Z,
    5. Liebschutz JM,
    6. Lasser KE
    . The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain. Subst Abus 2016;37:516–20.
    OpenUrl
  22. 22.↵
    1. Cochran G,
    2. Rubinstein J,
    3. Bacci JL,
    4. Ylioja T,
    5. Tarter R
    . Screening community pharmacy patients for risk of prescription opioid misuse. J Addict Med 2015;9:411–6.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Bradley KA,
    2. Lapham GT,
    3. Caldeiro R,
    4. Marx L
    . Single-item screens for prescription and illicit drug misuse largely identifies primary care patients with unrecognized drug use. J Patient-Centered Res Rev 2:132, 2015.
    OpenUrl
  24. 24.↵
    1. Ondersma SJ,
    2. Chase L,
    3. Svikis DS,
    4. Schuster CR
    . Computer-based brief intervention for perinatal drug use. J Subst Abuse Treat 2005;28:305–12.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Breland AB,
    2. Almond L,
    3. Kienzle J,
    4. Ondersma SJ,
    5. Hart A Jr..,
    6. Weaver M,
    7. Dillon P,
    8. Svikis D
    . Targeting tobacco in a community-based addiction recovery cohort: Results from a computerized, brief, randomized intervention trial. Contemp Clin Trials 2014;38:113–20.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Ewing JA
    . Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905–7.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Stevenson JS,
    2. Masters JA
    . Predictors of alcohol misuse and abuse in older women. J Nurs Scholarsh 2005;37:329–35.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Brown RL,
    2. Rounds LA
    . Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J 1995;94:135–40.
    OpenUrlPubMed
  29. 29.↵
    1. Knisely JS,
    2. Wunsch MJ,
    3. Cropsey KL,
    4. Campbell ED
    . Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat 2008;35:380–6.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 32 (2)
The Journal of the American Board of Family Medicine
Vol. 32, Issue 2
March-April 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments
Sebastian T. Tong, Kathryn M. Polak, Michael F. Weaver, Gabriela C. Villalobos, Wally R. Smith, Dace S. Svikis
The Journal of the American Board of Family Medicine Mar 2019, 32 (2) 272-278; DOI: 10.3122/jabfm.2019.02.180172

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments
Sebastian T. Tong, Kathryn M. Polak, Michael F. Weaver, Gabriela C. Villalobos, Wally R. Smith, Dace S. Svikis
The Journal of the American Board of Family Medicine Mar 2019, 32 (2) 272-278; DOI: 10.3122/jabfm.2019.02.180172
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Multiple Research Methodologies Can Advance the Science of Family Medicine
  • Google Scholar

More in this TOC Section

  • Factors Influencing Changing Scopes of Practice Among Contemporary Graduates of the Nation’s Largest Family Medicine Residency
  • Association of Social Needs with Diabetes Outcomes in an Older Population
  • Patient Perspectives on Delayed Specialty Follow-Up After a Primary Care Visit
Show more Brief Reports

Similar Articles

Keywords

  • Drug Abuse
  • Prevalence
  • Primary Health Care
  • Psychotropic Drugs
  • Substance Abuse Detection

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire